Back to search

Article

Navigating the Pharmaceutical Patent Landscape: Impact of Patent Cliffs on Innovation and Accessibility

2026-02-05

Abstract excerpt

This research paper analyses the impact of patent cliffs on both pharmaceutical firms and patients, focusing on the dynamics that emerge when brand-name drugs lose patent protection. Through an extensive literature review, the paper examines the various strategies employed by firms to mitigate the financial consequences of patent cliffs. Despite these efforts to preserve revenue, these strategies often have uninte...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
805dae0c-5812-5251-abeb-cb2c521ebb63
DOI
10.20944/preprints202602.0423.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Navigating the Pharmaceutical Patent Landscape: Impact of Patent Cliffs on Innovation and AccessibilityDOI 10.20944/preprints202602.0423.v1
A Case of Excessive, Opportunistic Price Increase of a Generic Oncology DrugSemantic proximity
§ 1498: A Guide to Government Patent Use, a Path to Licensing and Distributing Generic DrugsSemantic proximity
The Economics of Profit-Cap Policy: Big Pharma, Big Tech, and the Duopoly RuleSemantic proximity
Beyond Traditional IP: Addressing Regulatory BarriersSemantic proximity
The clinician impact and financial cost to the NHS of litigation over pregabalin: a cohort study in English primary careSemantic proximity
Strategic Use of Patent Opposition Safeguard to Improve Equitable Access to Innovative Health Technologies: A Case Study of CAR T-Cell Therapy KymriahSemantic proximity
The Role of Intellectual Property Rights on Access to Medicines in the WHO African Region: 25 Years After the TRIPS AgreementSemantic proximity
Avoiding the TRIPS Trap: A Path to Domestic Disclosure of Clinical Drug Data Consistent with International NormsSemantic proximity
What Ails Drug Supply Chains? A Model for Diagnosis and Suggestions for a CureSemantic proximity
Social and private value created through commercialization of Gilead Sciences’ innovative medicines for Hepatitis C and HIV: a cross-sectional analysisSemantic proximity
Availability of Different Branded Generic Vildagliptin after Off-patenting: An Observation from Eastern IndiaSemantic proximity
Recalibrating Patent Protection for COVID-19 Vaccines: A Path to Affordable Access and Equitable DistributionSemantic proximity
Select a neighboring publication to make it the new centre.